Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-06
DOI
10.1038/s41418-019-0484-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation
- (2019) Lijie Peng et al. ACS Medicinal Chemistry Letters
- Screening for Osteoporosis to Prevent Fractures
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coupling of bone resorption and formation by RANKL reverse signalling
- (2018) Yuki Ikebuchi et al. NATURE
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
- (2018) Sainan An et al. EBioMedicine
- SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis
- (2018) Zhiwei Jie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
- (2018) G. Vargas et al. ONCOGENE
- Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice
- (2017) Zu-Guo Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Carnosic acid alleviates hyperlipidemia and insulin resistance by promoting the degradation of SREBPs via the 26S proteasome
- (2017) Zhishen Xie et al. Journal of Functional Foods
- Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation
- (2016) Zu-Guo Zheng et al. BIOCHEMICAL PHARMACOLOGY
- Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
- (2016) Wei Wei et al. Cell Metabolism
- Osteocytes: The master cells in bone remodelling
- (2016) Matthew Prideaux et al. CURRENT OPINION IN PHARMACOLOGY
- Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation
- (2015) Kazuki Inoue et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Carnosic acid
- (2015) Simona Birtić et al. PHYTOCHEMISTRY
- High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms
- (2015) Chandi C. Mandal Frontiers in Endocrinology
- Identification of Novel Transcription Factors in Osteoclast Differentiation Using Genome-wide Analysis of Open Chromatin Determined by DNase-seq
- (2014) Kazuki Inoue et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cholesterol and breast cancer pathophysiology
- (2014) Erik R. Nelson et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Carboxyl Terminus of Hsp70-Interacting Protein Regulation of Osteoclast Formation in Mice Through Promotion of Tumor Necrosis Factor Receptor-Associated Factor 6 Protein Degradation
- (2014) Shan Li et al. Arthritis & Rheumatology
- Mechanisms of bone anabolism regulated by statins
- (2012) Feng Ruan et al. BIOSCIENCE REPORTS
- An energetic orphan in an endocrine tissue: A revised perspective of the function of estrogen receptor-related receptor alpha in bone and cartilage
- (2012) Edith Bonnelye et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
- (2012) Dennis L. Buckley et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Role of Cholesterol in the Development and Progression of Breast Cancer
- (2011) Gemma Llaverias et al. AMERICAN JOURNAL OF PATHOLOGY
- Disorders of Bone Remodeling
- (2011) Xu Feng et al. Annual Review of Pathology-Mechanisms of Disease
- Estrogen related receptors (ERRs): A new dawn in transcriptional control of mitochondrial gene networks
- (2011) Lillian J. Eichner et al. MITOCHONDRION
- PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
- (2010) Wei Wei et al. Cell Metabolism
- PPARγ in bone homeostasis
- (2010) Yihong Wan TRENDS IN ENDOCRINOLOGY AND METABOLISM
- ERR receptors as potential targets in osteoporosis
- (2010) Marlène Gallet et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Estrogen and ERα: Culprits in cervical cancer?
- (2010) Sang-Hyuk Chung et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation
- (2009) C. A. Derby et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells
- (2009) Rebecca A. Stein et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Transcriptional Control of Skeletogenesis
- (2008) Gerard Karsenty Annual Review of Genomics and Human Genetics
- Association between serum cholesterol and bone mineral density
- (2008) Joanna Makovey et al. BONE
- The significance of the expression of ERRα as a potential biomarker in breast cancer
- (2008) Katarzyna Jarzabek et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started